- RGLS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.5 million.
- RGLS has traded 112,947 shares today.
- RGLS is down 3.6% today.
- RGLS was up 10.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in RGLS with the Ticky from Trade-Ideas. See the FREE profile for RGLS NOW at Trade-Ideas More details on RGLS: Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. Currently there are 3 analysts that rate Regulus Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Regulus Therapeutics has been 1.4 million shares per day over the past 30 days. Regulus has a market cap of $788.8 million and is part of the health care sector and drugs industry. The stock has a beta of 1.79 and a short float of 38.6% with 3.32 days to cover. Shares are up 142.1% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.